Today we’re diving into the world of corticosteroids and hormonal therapies — essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. These molecules may be decades old, but their manufacturing remains highly complex and critical to patients worldwide.
Our guest is Olivier Roux, a Senior Director at Curia. He shares how Curia partners with both startups and big pharma to simplify steroid API challenges, solve supply issues, and prepare for next-generation innovations. If you want to understand what it really takes to bring these life-changing therapies to patients, stay tuned — this conversation is packed with insights you won’t want to miss.
01:39 Meet Olivier Roux
02:20 What corticosteroids and hormonal therapies are
04:40 Evolution of steroidal hormonal therapies
05:50 Common uses of corticosteroids today
07:40 Key drivers of market growth
10:06 Curia’s agile outsourcing solutions for steroids
16:05 Importance of particle size control for steroids
17:18 Aseptic processing and high potency handling
Podden och tillhörande omslagsbild på den här sidan tillhör
Labiotech. Innehållet i podden är skapat av Labiotech och inte av,
eller tillsammans med, Poddtoppen.
